Compare TXG & MLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TXG | MLCO |
|---|---|---|
| Founded | 2012 | 2004 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Hotels/Resorts |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.5B |
| IPO Year | 2019 | 2006 |
| Metric | TXG | MLCO |
|---|---|---|
| Price | $18.61 | $6.35 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 14 | 6 |
| Target Price | ★ $16.18 | $9.42 |
| AVG Volume (30 Days) | ★ 2.7M | 2.7M |
| Earning Date | 02-12-2026 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.26 |
| Revenue | $641,814,000.00 | ★ $5,061,044,000.00 |
| Revenue This Year | $4.94 | $13.28 |
| Revenue Next Year | N/A | $2.61 |
| P/E Ratio | ★ N/A | $23.69 |
| Revenue Growth | 1.92 | ★ 11.46 |
| 52 Week Low | $6.78 | $4.55 |
| 52 Week High | $23.56 | $10.15 |
| Indicator | TXG | MLCO |
|---|---|---|
| Relative Strength Index (RSI) | 38.96 | 34.06 |
| Support Level | $17.37 | $5.98 |
| Resistance Level | $20.49 | $6.32 |
| Average True Range (ATR) | 1.18 | 0.23 |
| MACD | -0.60 | 0.05 |
| Stochastic Oscillator | 8.89 | 27.20 |
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
Melco Resorts & Entertainment is one of only six licensed casino operators in Macao. It operates Altira, a complex focused on premium customers; City of Dreams, an integrated resort in Cotai serving both mass-market and premium patrons; and Mocha Clubs' electronic gaming machines. The company also has a majority interest in Studio City, which opened in 2015. Outside Macao, Melco owns City of Dreams Manila in the Philippines and City of Dreams Mediterranean in Cyprus. The business mix in terms of adjusted EBITDA was about 81% from Macao, with the rest largely from the Philippines as of 2024.